Sundaram Preethi sold CPRX
July 15, 2026 · Form 4 insider transaction
Sundaram Preethi sold 54,804 shares of Catalyst Pharmaceuticals Inc at $31.50 per share, a transaction worth $1.73M. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
54,804
Price
$31.50
Total value
$1.73M
InsiderSundaram Preethi
Role—
SecurityCommon Stock, par value $0.001 per share
Transaction codeD: Disposition to the issuer
Transaction dateJuly 15, 2026
Filing dateJuly 17, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported securities were disposed of in connection with the consummation of the acquisition of the Issuer by Angelini Pharma S.p.A. (the "Merger")